These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21255943)

  • 21. Prospective evaluation of concomitant tumour bed boost with whole breast irradiation in patients with locally advanced breast cancer undergoing breast-conserving therapy.
    Jalali R; Malde R; Bhutani R; Budrukkar A; Badwe R; Sarin R
    Breast; 2008 Feb; 17(1):64-70. PubMed ID: 17851077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy.
    Donovan E; Bleakley N; Denholm E; Evans P; Gothard L; Hanson J; Peckitt C; Reise S; Ross G; Sharp G; Symonds-Tayler R; Tait D; Yarnold J;
    Radiother Oncol; 2007 Mar; 82(3):254-64. PubMed ID: 17224195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant breast radiotherapy using a simultaneous integrated boost: clinical and dosimetric perspectives.
    Alford SL; Prassas GN; Vogelesang CR; Leggett HJ; Hamilton CS
    J Med Imaging Radiat Oncol; 2013 Apr; 57(2):222-9. PubMed ID: 23551785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cosmetic outcome and seroma formation after breast-conserving surgery with intraoperative radiation therapy boost for early breast cancer.
    Senthi S; Link E; Chua BH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e139-44. PubMed ID: 22560552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study.
    Toledano A; Garaud P; Serin D; Fourquet A; Bosset JF; Breteau N; Body G; Azria D; Le Floch O; Calais G
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):324-32. PubMed ID: 16542788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial.
    Poortmans PM; Collette L; Horiot JC; Van den Bogaert WF; Fourquet A; Kuten A; Noordijk EM; Hoogenraad W; Mirimanoff RO; Pierart M; Van Limbergen E; Bartelink H;
    Radiother Oncol; 2009 Jan; 90(1):80-5. PubMed ID: 18707785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast-conserving surgery? Results of the ARCOSEIN multicenter, Phase III study: patients' and doctors' views.
    Toledano AH; Bollet MA; Fourquet A; Azria D; Gligorov J; Garaud P; Serin D; Bosset JF; Miny-Buffet J; Favre A; LeFoch O; Calais G
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):66-72. PubMed ID: 17448869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial.
    Brouwers PJAM; van Werkhoven E; Bartelink H; Fourquet A; Lemanski C; van Loon J; Maduro JH; Russell NS; Scheijmans LJEE; Schinagl DAX; Westenberg AH; Poortmans P; Boersma LJ;
    Radiother Oncol; 2018 Sep; 128(3):434-441. PubMed ID: 29980320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cosmetic outcome and incidence of infection with the MammoSite breast brachytherapy applicator.
    Dickler A; Kirk MC; Choo J; Hsi WC; Chu J; Dowlatshahi K; Francescatti D; Shott S; Nguyen C
    Breast J; 2005; 11(5):306-10. PubMed ID: 16174149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome with interstitial brachytherapy boost in the treatment of women with early-stage breast cancer.
    Neumanova R; Petera J; Frgala T; Dusek L; Jarkovsky J; Kuricka R
    Neoplasma; 2007; 54(5):413-23. PubMed ID: 17688371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer.
    Chadha M; Vongtama D; Friedmann P; Parris C; Boolbol SK; Woode R; Harrison LB
    Clin Breast Cancer; 2012 Feb; 12(1):57-62. PubMed ID: 22056970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subsets of women with close or positive margins after breast-conserving surgery with high local recurrence risk despite breast plus boost radiotherapy.
    Lupe K; Truong PT; Alexander C; Lesperance M; Speers C; Tyldesley S
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e561-8. PubMed ID: 21514069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-year outcomes of breast intensity-modulated radiation therapy with simultaneous integrated boost.
    McDonald MW; Godette KD; Whitaker DJ; Davis LW; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):523-30. PubMed ID: 19775834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing cosmetic results after conservation therapy for breast cancer.
    Taylor ME; Perez CA; Halverson KJ; Kuske RR; Philpott GW; Garcia DM; Mortimer JE; Myerson RJ; Radford D; Rush C
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):753-64. PubMed ID: 7860386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient evaluation of cosmetic outcome after conserving surgery for treatment of primary breast cancer.
    Al-Ghazal SK; Fallowfield L; Blamey RW
    Eur J Surg Oncol; 1999 Aug; 25(4):344-6. PubMed ID: 10419701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial.
    Polgár C; Sulyok Z; Fodor J; Orosz Z; Major T; Takácsi-Nagy Z; Mangel LC; Somogyi A; Kásler M; Németh G
    J Surg Oncol; 2002 Jul; 80(3):121-8; discussion 129. PubMed ID: 12115793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Turning subjective into objective: the BCCT.core software for evaluation of cosmetic results in breast cancer conservative treatment.
    Cardoso MJ; Cardoso J; Amaral N; Azevedo I; Barreau L; Bernardo M; Christie D; Costa S; Fitzal F; Fougo JL; Johansen J; Macmillan D; Mano MP; Regolo L; Rosa J; Teixeira L; Vrieling C
    Breast; 2007 Oct; 16(5):456-61. PubMed ID: 17606373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial.
    Bartelink H; Horiot JC; Poortmans PM; Struikmans H; Van den Bogaert W; Fourquet A; Jager JJ; Hoogenraad WJ; Oei SB; Wárlám-Rodenhuis CC; Pierart M; Collette L
    J Clin Oncol; 2007 Aug; 25(22):3259-65. PubMed ID: 17577015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-fraction intraoperative radiotherapy for breast cancer: early cosmetic results.
    Beal K; McCormick B; Zelefsky MJ; Borgen P; Fey J; Goldberg J; Cohen GN; Sacchini V
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):19-24. PubMed ID: 17446003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous integrated boost in breast conserving treatment of breast cancer: a dosimetric comparison of helical tomotherapy and three-dimensional conformal radiotherapy.
    Hijal T; Fournier-Bidoz N; Castro-Pena P; Kirova YM; Zefkili S; Bollet MA; Dendale R; Campana F; Fourquet A
    Radiother Oncol; 2010 Mar; 94(3):300-6. PubMed ID: 20171752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.